Simultaneous quantification of acidic and basic flupirtine metabolites by supercritical fluid chromatography according to European Medicines Agency validation.
Flupirtine
Green chemistry
Halogen bonds
Metabolism
Supercritical fluid chromatography
Validation
Journal
Journal of chromatography. A
ISSN: 1873-3778
Titre abrégé: J Chromatogr A
Pays: Netherlands
ID NLM: 9318488
Informations de publication
Date de publication:
11 Oct 2019
11 Oct 2019
Historique:
received:
22
02
2019
revised:
15
04
2019
accepted:
24
04
2019
pubmed:
6
5
2019
medline:
24
10
2019
entrez:
7
5
2019
Statut:
ppublish
Résumé
Supercritical fluid chromatography (SFC) holds the potential to become an orthogonal method to HPLC/UHPLC in xenobiotic metabolism studies, due to its outstanding capacity to simultaneously separate highly similar (as HPLC) and physicochemically different analytes (problematic using HPLC). Paucity of guideline-conform validation, however, has been a major obstacle to clinical application of SFC, even in cases where biotransformation yields chemically dissimilar metabolites that require more than one HPLC method for comprehensive analysis. Here, a method based on supercritical fluid chromatography coupled to single quadrupole MS detection was developed to simultaneously quantify the divisive analgesic flupirtine and its acidic and basic metabolites, represented by 4-fluorohippuric acid (4-FHA) and the active metabolite D-13223 respectively, using custom-made synthetic internal standards. Experimental data on the fundamental retention mechanisms under supercritical conditions, indicating the importance of halogen and π-π-bonding for specific retention on polysaccharide-based stationary-phases, is discussed. Compared to previous HPLC methods, the novel method offers higher versatility in terms of the target metabolite range (addressing both acidic and basic metabolites within a singular method), faster analysis (7.5 min), and compliance with green chemistry principles. Validation was performed according to EMA criteria on bioanalytical method validation, demonstrating selectivity, carry-over, calibration curve parameters (LLOQ, range, and linearity), within- and between-run accuracy and precision, dilution integrity, matrix effect and stability. For proof-of-concept, the SFC method was applied to clinical samples of human urine obtained after single intravenous (100 mg), single oral (100 mg), and repeated oral administration (400 mg). Flupirtine, D-13223, and 4-FHA could be quantified, shedding light on the extent of oxidative flupirtine metabolism in humans in the context of the unresolved biotoxification that has led to the withdrawal of specific neuronal K
Identifiants
pubmed: 31056272
pii: S0021-9673(19)30452-2
doi: 10.1016/j.chroma.2019.04.067
pii:
doi:
Substances chimiques
Acids
0
Aminopyridines
0
Analgesics
0
Solvents
0
flupirtine
MOH3ET196H
Types de publication
Journal Article
Randomized Controlled Trial
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
338-347Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.